Literature DB >> 18296663

Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1.

Hyeong Gon Yu1, Xiaoqing Liu, Szilard Kiss, Edward Connolly, Evangelos S Gragoudas, Norman A Michaud, Oleg V Bulgakov, Michael Adamian, Margaret M DeAngelis, Joan W Miller, Tiansen Li, Ivana K Kim.   

Abstract

PURPOSE: Age-related degradation of the elastic lamina in Bruch's membrane may have a permissive effect on the growth of choroidal neovascularization (CNV). This study investigated the influence of defective elastic fiber maintenance in the development of laser-induced CNV.
METHODS: A mouse lacking lysyl oxidase-like (LOXL)-1, an enzyme essential for elastin polymerization, was studied. The morphologic characteristics of the elastic lamina within Bruch's membrane were examined in mutant and wild-type (WT) eyes. Laser-induced CNV was evaluated by fluorescein angiography and choroidal flat mounts. Immunohistochemistry for elastin was performed on the CNV lesions, and vascular endothelial growth factor (VEGF) levels were determined by ELISA. Soluble elastin and matrix metalloproteinase (MMPs) levels were also analyzed by immunoblotting.
RESULTS: The elastic lamina of Bruch's membrane in the LOXL1-deficient mice was fragmented and less continuous than in the WT controls. The mutant mice showed increased levels of soluble elastin peptides and reduced elastin polymer deposition in neovascular membranes. Significantly larger CNV with greater leakage on fluorescein angiography developed in mutant mice. VEGF levels in the RPE/choroid were higher in the knockout mice on days 7 and 14 after laser (P < 0.05). MT1-MMP (MMP14) was also elevated after laser in the LOXL1 mutant eyes compared to the WT controls.
CONCLUSIONS: These results show that a systemic defect in elastic fiber deposition affects Bruch's membrane integrity and leads to more aggressive CNV growth. The latter may be partially mediated by abnormal signaling from the accumulation of soluble elastin peptides.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18296663      PMCID: PMC2770799          DOI: 10.1167/iovs.07-1508

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  22 in total

1.  Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroid.

Authors:  L Guo; A A Hussain; G A Limb; J Marshall
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-10       Impact factor: 4.799

2.  Risk factors in age-related maculopathy complicated by choroidal neovascularization.

Authors:  M S Blumenkranz; S R Russell; M G Robey; R Kott-Blumenkranz; N Penneys
Journal:  Ophthalmology       Date:  1986-05       Impact factor: 12.079

3.  Bruch's membrane and disease of the macula. Role of elastic tissue and collagen.

Authors:  M J Hogan
Journal:  Trans Ophthalmol Soc U K       Date:  1967

4.  Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP.

Authors:  Arnaud Robinet; Abdel Fahem; Jean-Hubert Cauchard; Eric Huet; Loïc Vincent; Sandrine Lorimier; Franck Antonicelli; Claudine Soria; Michel Crepin; William Hornebeck; Georges Bellon
Journal:  J Cell Sci       Date:  2005-01-04       Impact factor: 5.285

5.  Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration.

Authors:  N H Victor Chong; Jason Keonin; Phil J Luthert; Christina I Frennesson; David M Weingeist; Rachel L Wolf; Robert F Mullins; Gregory S Hageman
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

6.  MMP-2 and MMP-9 synergize in promoting choroidal neovascularization.

Authors:  Vincent Lambert; Ben Wielockx; Carine Munaut; Catherine Galopin; Maud Jost; Takeshi Itoh; Zena Werb; Andrew Baker; Claude Libert; Hans-Willi Krell; Jean-Michel Foidart; Agnès Noël; Jean-Marie Rakic
Journal:  FASEB J       Date:  2003-10-16       Impact factor: 5.191

7.  Missense variations in the fibulin 5 gene and age-related macular degeneration.

Authors:  Edwin M Stone; Terry A Braun; Stephen R Russell; Markus H Kuehn; Andrew J Lotery; Paula A Moore; Christopher G Eastman; Thomas L Casavant; Val C Sheffield
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

8.  Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes.

Authors:  B Steen; S Sejersen; L Berglin; S Seregard; A Kvanta
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-10       Impact factor: 4.799

9.  Elastic fiber homeostasis requires lysyl oxidase-like 1 protein.

Authors:  Xiaoqing Liu; Yun Zhao; Jiangang Gao; Basil Pawlyk; Barry Starcher; Jeffrey A Spencer; Hiromi Yanagisawa; Jian Zuo; Tiansen Li
Journal:  Nat Genet       Date:  2004-01-25       Impact factor: 38.330

10.  MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix.

Authors:  Tae-Hwa Chun; Farideh Sabeh; Ichiro Ota; Hedwig Murphy; Kevin T McDonagh; Kenn Holmbeck; Henning Birkedal-Hansen; Edward D Allen; Stephen J Weiss
Journal:  J Cell Biol       Date:  2004-11-15       Impact factor: 10.539

View more
  22 in total

1.  In-vivo and ex-vivo characterization of laser-induced choroidal neovascularization variability in mice.

Authors:  Robert Hoerster; Philipp S Muether; Sarah Vierkotten; Susanne Schröder; Bernd Kirchhof; Sascha Fauser
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-16       Impact factor: 3.117

Review 2.  Treatment of age-related macular degeneration: beyond VEGF.

Authors:  Joan W Miller
Journal:  Jpn J Ophthalmol       Date:  2010-12-30       Impact factor: 2.447

3.  Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF.

Authors:  Stephen J Kim; Hassanain S Toma; Joshua M Barnett; John S Penn
Journal:  Exp Eye Res       Date:  2010-07-24       Impact factor: 3.467

4.  Reduced choroidal neovascular membrane formation in cyclooxygenase-2 null mice.

Authors:  Kasra A Rezaei; Hassanain S Toma; Jiyang Cai; John S Penn; Paul Sternberg; Stephen J Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-03       Impact factor: 4.799

Review 5.  Next-generation therapeutic solutions for age-related macular degeneration.

Authors:  Khrishen Cunnusamy; Rafael Ufret-Vincenty; Shusheng Wang
Journal:  Pharm Pat Anal       Date:  2012-05

6.  Transcriptome analysis and molecular signature of human retinal pigment epithelium.

Authors:  N V Strunnikova; A Maminishkis; J J Barb; F Wang; C Zhi; Y Sergeev; W Chen; A O Edwards; D Stambolian; G Abecasis; A Swaroop; P J Munson; S S Miller
Journal:  Hum Mol Genet       Date:  2010-04-01       Impact factor: 6.150

7.  Elastin-mediated choroidal endothelial cell migration: possible role in age-related macular degeneration.

Authors:  Jessica M Skeie; Robert F Mullins
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-15       Impact factor: 4.799

8.  Disruption of the blood-aqueous barrier and lens abnormalities in mice lacking lysyl oxidase-like 1 (LOXL1).

Authors:  Janey L Wiggs; Basil Pawlyk; Edward Connolly; Michael Adamian; Joan W Miller; Louis R Pasquale; Ramez I Haddadin; Cynthia L Grosskreutz; Douglas J Rhee; Tiansen Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-10       Impact factor: 4.799

9.  In-vivo investigation of laser-induced choroidal neovascularization in rat using spectral-domain optical coherence tomography (SD-OCT).

Authors:  Tao Liu; Ling Hui; Yu-sheng Wang; Jian-qiang Guo; Rong Li; Jing-bo Su; Jian-kang Chen; Xue-mei Xin; Wei-hua Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-01       Impact factor: 3.117

Review 10.  Genetics of pseudoexfoliation syndrome.

Authors:  Pratap Challa
Journal:  Curr Opin Ophthalmol       Date:  2009-03       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.